指南与共识胸部骨肌CTDR

意大利风湿病学会关于类风湿关节炎合并间质性肺疾病患者治疗的指南

The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung disease.
指南 / 共识 · Reumatismo · 2025-11-10

意大利风湿病学会依据国家指南体系要求制定类风湿关节炎合并间质性肺疾病(RA-ILD)国家临床实践指南,经系统评价证据并由风湿病学、呼吸病学、放射学专家及患者代表咨询后,分三个主要场景给出推荐,证据缺乏处采用专家共识形成良好临床实践指南。

要点

  • 指南分三部分:RA治疗药物在RA-ILD中的安全性有效性、ILD治疗药物在RA-ILD中的疗效安全性、一线失败后的药物选择。
  • 多学科治疗模式与肺移植等缺乏科学证据的主题,通过专家共识形成良好临床实践指南。
  • 指南旨在为意大利RA-ILD患者管理提供特异且基于证据的推荐,以改善健康管理并降低发病率与死亡率负担。

核心结论

  • 该指南是改善意大利风湿病患者健康管理的关键一步,为RA-ILD管理提供特异且基于证据的指南,旨在促进健康并降低这一脆弱人群的发病率与死亡率负担。

研究设计与样本

  • 意大利风湿病学会依据国家卫生研究院国家指南体系要求制定国家临床实践指南,流程包括对现有证据的系统评价及其对意大利背景的适用性评估,随后咨询风湿病学、呼吸疾病、放射学专家及卫生专业与患者代表。

临床应用与阅片要点

  • 推荐分三个主要场景:第一部分聚焦RA治疗药物,评估其在RA-ILD中的安全性与有效性。
  • 第二部分覆盖用于治疗RA-ILD患者ILD的药物,评估其在RA患者中的疗效与安全性。
  • 第三部分涉及一线治疗失败后用于治疗RA-ILD的药物。
  • 对多学科治疗模式的价值与肺移植等缺乏科学证据的主题,决定通过专家共识制定良好临床实践指南。

局限性

  • 原文指出某些主题如多学科治疗模式的价值和肺移植在文献中缺乏或没有科学证据,故决定通过专家共识制定良好临床实践指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: In the absence of national and European guidelines on the treatment of rheumatoid arthritis (RA) with interstitial lung disease (ILD), the Italian Society of Rheumatology decided to develop national clinical practice guidelines on the management of patients with RA-ILD in accordance with the requirements of the National Guideline System of the National Institute of Health.

METHODS: The development process included a systematic review of the available evidence and its adaptability to the Italian context, followed by a consultation with experts in rheumatology, respiratory diseases, radiology, and representatives of the health professions and patients.

RESULTS: The panel decided to develop recommendations in three main scenarios. The first section of recommendations is focused on drugs indicated for RA to assess their safety and efficacy in RA-ILD. The second set of recommendations covered the drugs indicated for the treatment of ILD in patients with RA-ILD (to assess their efficacy and safety in patients with RA). The third part of these guidelines dealt with drugs indicated for the treatment of RA-ILD upon first-line failure. Moreover, the lack or absence of scientific evidence in literature on certain topics, such as the value of a multidisciplinary treatment approach and lung transplantation, led to the decision to proceed through expert consensus to develop good clinical practice guidelines.

CONCLUSIONS: These guidelines represent a fundamental step towards improving the health management of patients with rheumatological diseases in Italy by providing specific and evidence-based guidelines for the management of RA-ILD. Their use is intended to promote health and reduce the burden of morbidity and mortality in this vulnerable population.

来源:Reumatismo,查看原文。版权归原作者所有。

引用

  1. Crotti C, Ughi N, Scirè CA, et al. The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung disease. Reumatismo. 2025. PMID: 41247141. doi:10.4081/reumatismo.2025.1865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。